Search by Drug Name or NDC
NDC 64406-0011-01 Plegridy 125 ug/.5mL Details
Plegridy 125 ug/.5mL
Plegridy is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is PEGINTERFERON BETA-1A.
MedlinePlus Drug Summary
Peginterferon beta-1a injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including the following: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Peginterferon beta-1a injection is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 64406-0011-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Peginterferon Beta-1a Injection
Product Information
| NDC | 64406-0011 |
|---|---|
| Product ID | 64406-011_488569c2-1737-414d-9d48-0ad5567a38f6 |
| Associated GPIs | 6240307530D220 |
| GCN Sequence Number | 072682 |
| GCN Sequence Number Description | peginterferon beta-1a PEN INJCTR 125MCG/0.5 SUBCUT |
| HIC3 | H0E |
| HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
| GCN | 36958 |
| HICL Sequence Number | 041331 |
| HICL Sequence Number Description | PEGINTERFERON BETA-1A |
| Brand/Generic | Brand |
| Proprietary Name | Plegridy |
| Proprietary Name Suffix | Pen |
| Non-Proprietary Name | peginterferon beta-1a |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | PEGINTERFERON BETA-1A |
| Labeler Name | Biogen Inc. |
| Pharmaceutical Class | Interferon beta [EPC], Interferon-beta [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125499 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64406-0011-01 (64406001101)
| NDC Package Code | 64406-011-01 |
|---|---|
| Billing NDC | 64406001101 |
| Package | 1 TRAY in 1 CARTON (64406-011-01) / 2 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE (64406-011-02) |
| Marketing Start Date | 2014-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |